These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18188512)

  • 1. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
    van Zyl LT; Lespérance F; Frasure-Smith N; Malinin AI; Atar D; Laliberté MA; Serebruany VL
    J Thromb Thrombolysis; 2009 Jan; 27(1):48-56. PubMed ID: 18188512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
    Serebruany VL; Glassman AH; Malinin AI; Nemeroff CB; Musselman DL; van Zyl LT; Finkel MS; Krishnan KR; Gaffney M; Harrison W; Califf RM; O'Connor CM;
    Circulation; 2003 Aug; 108(8):939-44. PubMed ID: 12912814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-related biomarkers and their response to inhibition with aspirin and p2y
    Lowenstern A; Storey RF; Neely M; Sun JL; Angiolillo DJ; Cannon CP; Himmelmann A; Huber K; James SK; Katus HA; Morais J; Siegbahn A; Steg PG; Wallentin L; Becker RC;
    J Thromb Thrombolysis; 2017 Aug; 44(2):145-153. PubMed ID: 28608165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.
    Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC;
    JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
    Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
    Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial.
    Hirsh-Rokach B; Spectre G; Shai E; Lotan A; Ritter A; Al-Aieshy F; Malmström RE; Varon D; Alcalai R
    Pharmacotherapy; 2015 Feb; 35(2):140-7. PubMed ID: 25689244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
    Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants.
    Li X; Fan Y; Xiao S; Peng S; Dong X; Zheng X; Liu CC; Li H; Xiao Z
    J Affect Disord; 2015 Nov; 187():84-90. PubMed ID: 26321259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression.
    Serebruany VL; Suckow RF; Cooper TB; O'Connor CM; Malinin AI; Krishnan KR; van Zyl LT; Lekht V; Glassman AH;
    Am J Psychiatry; 2005 Jun; 162(6):1165-70. PubMed ID: 15932816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel.
    Cha JK; Jeong MH; Lee KM; Bae HR; Lim YJ; Park KW; Cheon SM
    J Thromb Thrombolysis; 2002 Oct; 14(2):145-50. PubMed ID: 12714834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
    Muller O; Hamilos M; Bartunek J; Ulrichts H; Mangiacapra F; Holz JB; Ntalianis A; Trana C; Dierickx K; Vercruysse K; De Bruyne B; Wijns W; Barbato E
    Am J Cardiol; 2010 Feb; 105(3):333-8. PubMed ID: 20102944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.
    Wilson AM; Brittenden J; Bachoo P; Ford I; Nixon GF
    J Vasc Surg; 2009 Oct; 50(4):861-9. PubMed ID: 19786240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease.
    Ford I; Scott NW; Herd V; Mitchell LR; Williams DJ; Brittenden J
    J Am Coll Cardiol; 2014 Jan; 63(3):233-9. PubMed ID: 24211510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
    Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment.
    Lopez-Vilchez I; Serra-Millas M; Navarro V; Rosa Hernandez M; Villalta J; Diaz-Ricart M; Gasto C; Escolar G; Galan AM
    J Affect Disord; 2014 Apr; 159():39-45. PubMed ID: 24679387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prasugrel as opposed to clopidogrel improves endothelial nitric oxide bioavailability and reduces platelet-leukocyte interaction in patients with unstable angina pectoris: A randomized controlled trial.
    Rudolph TK; Fuchs A; Klinke A; Schlichting A; Friedrichs K; Hellmich M; Mollenhauer M; Schwedhelm E; Baldus S; Rudolph V
    Int J Cardiol; 2017 Dec; 248():7-13. PubMed ID: 28709700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Diabetes; 2005 Aug; 54(8):2430-5. PubMed ID: 16046311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).
    Frasure-Smith N; Koszycki D; Swenson JR; Baker B; van Zyl LT; Laliberté MA; Abramson BL; Lambert J; Gravel G; Lespérance F
    Psychosom Med; 2006; 68(1):87-93. PubMed ID: 16449416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
    Jain N; Wan F; Kothari M; Adelodun A; Ware J; Sarode R; Hedayati SS
    BMC Nephrol; 2019 Oct; 20(1):395. PubMed ID: 31664940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.